The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 21, 2016
Filed:
Apr. 03, 2014
Applicant:
Cellerant Therapeutics, Inc., San Carlos, CA (US);
Inventor:
Holger Karsunky, Redwood City, CA (US);
Assignee:
Cellerant Therapeutics, Inc., San Carlos, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/28 (2013.01); G01N 33/56966 (2013.01); G01N 33/57426 (2013.01); A61K 2039/505 (2013.01); C07K 2317/73 (2013.01); G01N 2333/726 (2013.01); G01N 2800/52 (2013.01); Y10T 436/143333 (2015.01);
Abstract
The disclosure relates to methods and compositions effective in the diagnosis, prognosis and treatment of human hematopoietic cancers. In particular, the disclosure provides tumor-associated genes that encode for cytokine receptors that are differentially expressed in hematopoietic tumor cells of myeloid origin compared with other cells, e.g., normal stem cells.